SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

16 Feb 2024 Evaluate
The company's total revenue for the quarter ended December 2023 saw a slight change in the total revenue, having registered a total revenue of Rs. 239.99 millions.The Profit  for the quarter ended December 2023 of  Rs. 34.21  millions  grew by 83.24% from Rs. 18.67 millions.Operating profit for the quarter ended December 2023 rose to 54.57 millions as compared to 32.68 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 239.99 229.33 4.65 728.21 712.57 2.19 957.49 750.74 27.54
Other Income 2.29 0.38 502.63 2.90 2.07 40.10 2.38 1.84 29.35
PBIDT 54.57 32.68 66.98 170.13 130.30 30.57 184.46 164.39 12.21
Interest 0.20 0.30 -33.33 0.63 1.07 -41.12 1.33 4.54 -70.70
PBDT 54.37 32.38 67.91 169.50 129.23 31.16 183.13 159.85 14.56
Depreciation 8.65 7.43 16.42 25.44 23.86 6.62 32.33 32.81 -1.46
PBT 45.72 24.95 83.25 144.06 105.37 36.72 150.80 127.04 18.70
TAX 11.51 6.28 83.28 36.25 26.52 36.69 37.45 34.90 7.31
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.50 1.45 -134.48
PAT 34.21 18.67 83.24 107.81 78.85 36.73 113.35 92.14 23.02
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 22.74 14.25 59.57 23.36 18.29 27.76 19.26 21.90 -12.02
Peers
Company Name CMP
Sun Pharma Inds. 1692.90
Dr. Reddys Lab 1220.70
Cipla 1229.70
Zydus Lifesciences 938.90
Lupin 2319.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×